Clinical Trials Browser

Phase 1/2 × siremadlin × Clear all

NCT05180695 2026-02-10

AMPHISARC

Phase 1/2 Active not recruiting

Sarcoma

NCT03760445 2020-01-09

HDM201 Added to CT in R/R or Newly Diagnosed AML

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual